These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 34109546)
1. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis. Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546 [TBL] [Abstract][Full Text] [Related]
2. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells. Ma S; Wang X; Zhang Z; Liu D Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007 [TBL] [Abstract][Full Text] [Related]
3. The role of EMG1 in lung adenocarcinoma progression: Implications for prognosis and immune cell infiltration. Wu X; Wu Z; Xie Z; Huang H; Wang Y; Lv K; Yang H; Liu X Int Immunopharmacol; 2024 Sep; 138():112553. PubMed ID: 38943975 [TBL] [Abstract][Full Text] [Related]
4. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related]
5. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway. Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinoma. Zhang L; Wang S; Wang L BMC Cancer; 2024 Oct; 24(1):1235. PubMed ID: 39375639 [TBL] [Abstract][Full Text] [Related]
7. SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression. He Y; Wang Y; Luo Z; Zhang X; Bai H; Wang J Cell Signal; 2024 Aug; 120():111216. PubMed ID: 38729325 [TBL] [Abstract][Full Text] [Related]
8. GALNT2 promotes cell proliferation, migration, and invasion by activating the Notch/Hes1-PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma. Wang W; Sun R; Zeng L; Chen Y; Zhang N; Cao S; Deng S; Meng X; Yang S Life Sci; 2021 Jul; 276():119439. PubMed ID: 33785338 [TBL] [Abstract][Full Text] [Related]
9. Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging. Lu T; Qiu T; Han B; Wang Y; Sun X; Qin Y; Liu A; Ge N; Jiao W Cell Oncol (Dordr); 2021 Apr; 44(2):297-310. PubMed ID: 33118120 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma. Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091 [TBL] [Abstract][Full Text] [Related]
11. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma. Ma G; Yang L; Dong J; Zhang L Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009 [TBL] [Abstract][Full Text] [Related]
12. DUS4L suppresses invasion and metastasis in LUAD via modulation of PI3K/AKT and ERK/MAPK signaling through GRB2. Li Z; Zhao PL; Gao X; Li X; Meng YQ; Li ZQ; Zhai KR; Wei SL; Feng HM; Huang HR; Li B Int Immunopharmacol; 2024 Dec; 142(Pt A):113043. PubMed ID: 39216120 [TBL] [Abstract][Full Text] [Related]
13. SGO2 as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma. Chen Y; Xiang T Front Biosci (Landmark Ed); 2024 Aug; 29(9):314. PubMed ID: 39344317 [TBL] [Abstract][Full Text] [Related]
14. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma. Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605 [TBL] [Abstract][Full Text] [Related]
15. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma. Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692 [TBL] [Abstract][Full Text] [Related]
16. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133 [TBL] [Abstract][Full Text] [Related]
17. LncRNA LINC00680 promotes lung adenocarcinoma growth via binding to GATA6 and canceling GATA6-mediated suppression of SOX12 expression. Sun X; Wang R; Tan M; Tian X; Meng J Exp Cell Res; 2021 Aug; 405(1):112653. PubMed ID: 34029572 [TBL] [Abstract][Full Text] [Related]
18. RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway. Zhang D; Jiang Q; Ge X; Shi Y; Ye T; Mi Y; Xie T; Li Q; Ye Q Int J Biol Sci; 2021; 17(10):2622-2632. PubMed ID: 34326698 [TBL] [Abstract][Full Text] [Related]
19. Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma. Li A; Zhang K; Zhou J; Li M; Fan M; Gao H; Ma R; Gao L; Chen M Int J Biol Macromol; 2024 Jun; 272(Pt 2):132797. PubMed ID: 38848833 [TBL] [Abstract][Full Text] [Related]
20. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis. Ren P; Hong X; Chang L; Xing L; Zhang H Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]